Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients

Onal C., Ozyigit G., Cem G., Hurmuz P., Torun N., Tuncel M., ...More

RADIOTHERAPY AND ONCOLOGY, vol.151, pp.222-227, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 151
  • Publication Date: 2020
  • Doi Number: 10.1016/j.radonc.2020.08.021
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, Gender Studies Database, MEDLINE, DIALNET
  • Page Numbers: pp.222-227
  • Keywords: Prostate cancer, Radiotherapy, Prostate-specific membrane antigen, Positron emission tomography, Treatment volume, RADICAL PROSTATECTOMY, RADIATION ONCOLOGY, PATTERNS, FAILURE, ADENOCARCINOMA, IRRADIATION, THERAPY, PET/CT
  • Hacettepe University Affiliated: Yes


Purpose: To evaluate the distribution of metastatic lymph nodes (LN) detected on Ga-68-PSMA-positron emission tomography/computed tomography (PET/CT) in treatment-naive prostate cancer (PC) patients and to analyze the LN coverage rates of the pelvic fields defined in the GETUG trial and RTOG guidelines and a pelvic field extending superiorly from the L4/L5 interspace.